Anúncio
Anúncio

CANF

CANF logo

Can-Fite BioPharma Ltd. - ADR

4.19
USD
Patrocinado
-0.17
-3.90%
09 de jan., 15:51 UTC -5
Encerrado
exchange

Pós-Mercado

4.16

-0.03
-0.72%

Relatórios de Lucros CANF

Rácio de surpresa positiva

CANF separação 4 de 4 últimas estimativas.

100%

Próximo Relatório

Data do Próximo Relatório
12 de abr. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q-- -- (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
--

Can-Fite BioPharma Ltd. - ADR earnings per share and revenue

On --, CANF reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q-- --, Can-Fite BioPharma Ltd. - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 12 de abr. de 2026.
Based on -- analistas, Can-Fite BioPharma Ltd. - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio